Damora Therapeutics, Inc (DMRA)
NGS · Common · CUSIP 36322Q107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DMRA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
36322Q107
Market Cap
Micro Cap
IPO
10/29/2020 · $15.00/share
Previous Symbol
GLTO (changed 3/10/2026)
Previous Name
Galecto, Inc.
Business: Damora Therapeutics, Inc. is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The Company's goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes.

Company Contact

CEO
Jennifer Jarrett
CFO
Jonathan Freve
Headquarters
75 State Street, Suite 100, Boston, MA 02109
Email Form
Contact Form »
SEC EDGAR Filings
View filings »